ATAI LIFE SCIENCES BV
NASDAQ: ATAI (AtaiBeckley Inc.)
Last update: 9 hours ago7.28
-0.11 (-1.49%)
| Previous Close | 7.39 |
| Volume | 119,739,666 |
| Price / Sales | 516.98 |
| Price / Book | 15.54 |
| 52 Weeks Range |
| Operating Margin (TTM) | -1,239.23% |
| Diluted EPS (TTM) | -0.910 |
| Quarterly Revenue Growth (YOY) | -54.00% |
| Total Debt/Equity (MRQ) | 19.02% |
| Current Ratio (MRQ) | 4.07 |
| Operating Cash Flow (TTM) | -77.70 M |
| Levered Free Cash Flow (TTM) | -47.04 M |
| Return on Assets (TTM) | -26.04% |
| Return on Equity (TTM) | -79.43% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | AtaiBeckley Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -5.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 0.5 |
| Average | -2.33 |
|
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 7.78% |
| % Held by Institutions | 31.48% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Candriam S.C.A. | 30 Jun 2026 | 3,039,399 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |